A new market study, titled “Global Biological API Drug Manufacturing Market – 2019-2026” has been featured on WiseGuyReports.
GLOBAL Biological API Drug Manufacturing Market Overview
The biological API involved in the fermentation of microorganisms and cultured in a substrate to produce a substance which is used in for treating disease eg: antibiotics, steroids and vaccines and other biological molecules used for the production of vaccines and genetically modified vaccines.
The surge in demand for biotechnology products and ongoing research by biopharmaceutical companies on therapeutic diseases majorly cancer, followed by autoimmune and cardiovascular diseases are driving the global biological API drug manufacturing. The rise in disease population in therapeutic categories will boost the innovation in novel biologic substances is additionally amplifying the growth of the market.
As of 2018, 12 pharmaceutical and life science companies and 13 non profit organizations along with USFDA and NIH joined the AMP program. This program focuses on developing novel treatment for Alzheimer disease, type2 diabetes, autoimmune disorders, etc.
Global biological API drug manufacturing market is segmented by manufacturing type, expression platform, application, and region. Manufacturing type includes In-House manufacturing and API Contract manufacturing, expression platform includes mammalian cell culture, microbial fermentation, and other expression platforms. By application includes monoclonal antibody (mAb) therapies, vaccines, insulin therapies, interferon therapies, and growth hormones.
API contract manufacturing dominates the global biological API drug manufacturing market during the forecast period due to its extensive usage of CMO’s by small and medium companies due to lack of complex manufacturing capabilities, capital-intensive nature of the business and high profitability associated in contracting with CMO for both clinical and commercial stage manufacturing.
According to European Pharmaceutical review in October 2018, currently 2/3rd of manufacturing – whether in the development stage or after commercial launch is outsourced.
Global Biological API Drug Manufacturing Market – Geographical Analysis
The global biological API drug manufacturing market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.
North America dominates the global biological API drug manufacturing market during the forecast period due to the high presence of key manufacturing service providers (CMO) in the region, shift from chemical synthesis to biological API, government approvals for production of novel drugs and high investments by the pharmaceuticals companies in R&D of Drugs.
Request Free Sample Report at https://www.wiseguyreports.com/sample-request/3792080-global-biological-api-drug-manufacturing-market-2019-2026
Global Biological API Drug Manufacturing Market – Competitive Analysis
New Product launches and mergers between key players for the development of novel technologies using Biological API are driving the global Biological API Drug Manufacturing Market.
In September 2017, Lonza Launched XS™ Pichia 2.0 Expression and Manufacturing Platform for Development of Next Generation Therapeutics.
In November 2018, Boehringer Ingelheim and Epizyme, Inc. merged for R&D and commercialization of novel small molecule inhibitors directed toward two previously unaddressed epigenetic targets as potential therapies for people with cancer.
Major market players in the Biological API Drug Manufacturing Market are Lonza, Boehringer Ingelheim BioXcellence, Celltrion, DSM Biologics, Samsung BioLogics, Fujifilm Diosynth Biotechnologies, and Others.
- Equipment Suppliers/ Buyers
- Service Providers/ Buyers
- Industry Investors/Investment Bankers
- Education & Research Institutes
- Research Professionals
- Emerging Companies
Table of Content
- Global Biological API Drug Manufacturing Market Methodology and Scope
- Global Biological API Drug Manufacturing Market – Market Definition and Disease Overview
- Global Biological API Drug Manufacturing Market – Market Dynamics
- Global Biological API Drug Manufacturing Market – Industry Forces
- Global Biological API Drug Manufacturing Market – By Manufacturing Type
- Global Biological API Drug Manufacturing Market – By Expression Platforms
- Global Biological API Drug Manufacturing Market – By Application
- Global Biological API Drug Manufacturing Market – By Region
- Global Biological API Drug Manufacturing Market – Competitive Landscape
- Company Profiles
12.Global Biological API Drug Manufacturing Market – Premium Insights
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)